Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the developing, producing, and selling of food and feed additives in China and internationally. The company offe...
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
SHENGDA BIO-PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 53.34 million yuan, a year-on-year increase of 146.04%
SHENGDA BIO-PHARM released its first-quarter performance, with a net profit attributable to the parent company of 21.7095 million yuan, a year-on-year increase of 469.35%
Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoon
SHENGDA BIO-PHARM: Wanjian Investment reduced its stake in the company by 1.36%
SHENGDA BIO-PHARM and others established a technology company including retail business for publications